Bio-Thera Solutions (SHSE:688177) 3-Year EBITDA Growth Rate : 13.60% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Bio-Thera Solutions 3-Year EBITDA Growth Rate?

Bio-Thera Solutions's EBITDA per Share for the three months ended in Mar. 2024 was ¥-0.28.

During the past 3 years, the average EBITDA Per Share Growth Rate was 13.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Bio-Thera Solutions was 30.10% per year. The lowest was 13.60% per year. And the median was 21.85% per year.

Competitive Comparison of Bio-Thera Solutions's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Bio-Thera Solutions's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio-Thera Solutions's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Thera Solutions's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Bio-Thera Solutions's 3-Year EBITDA Growth Rate falls into.

Bio-Thera Solutions 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Bio-Thera Solutions (SHSE:688177) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Bio-Thera Solutions 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Bio-Thera Solutions's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Thera Solutions (SHSE:688177) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Thera Solutions Ltd (SHSE:688177) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

5th Floor, Building A6, 11 Kaiyuan Avenue, Guangzhou High-tech Industrial Development Zone, Science City, Guangdong Province, Guangzhou, CHN, 510530

Website

https://www.bio-thera.com

Bio-Thera Solutions Ltd is engaged in research, development, and production of drugs and biosimilars. The company provides drug research and development; biotechnology consulting and communication services; services; medical research and experimental development; biological drug manufacturing; and pharmaceuticals retail.

Bio-Thera Solutions (SHSE:688177) Headlines

No Headlines